The short answer
Follow the advice to avoid grapefruit fruit and juice while taking oral verapamil. Juice can raise verapamil exposure, although small studies did not consistently show an increase or demonstrate toxicity.
What this answer covers
Oral verapamil with grapefruit flesh. The clinical PK studies used juice, while NHS guidance explicitly includes fruit.
- Supplement or preparation
- Grapefruit flesh
- Medication ingredient
- verapamil
What the positive study measured
In nine healthy volunteers, repeated grapefruit juice increased exposure to the two verapamil forms by about 28% and 36%. Blood pressure, heart rate and the measured ECG interval did not differ significantly. The label describes this concentration increase and says clinical consequences were not expected from that study.
Why the results are not uniform
A separate short study in ten hypertensive patients taking short-acting verapamil found no significant exposure increase after grapefruit juice. The amount, repeated versus single use, formulation and individual metabolism matter. Neither small study establishes the risk of toxicity from grapefruit flesh or every extract.
Follow the fruit and juice precaution
Current NHS guidance explicitly advises avoiding both grapefruit and its juice with verapamil. That clinical precaution is broader than the measured juice results. Do not substitute a guessed hours-long gap or use grapefruit to increase medication strength. Ask a pharmacist about any concentrated Citrus paradisi product.
If you have already had grapefruit
Tell your pharmacist or prescriber what you consumed, how much, and which verapamil formulation you take. Keep prescribed treatment unless they advise a change. If you feel dizzy, avoid driving; fainting, marked weakness or a slow pulse warrants prompt medical assessment.
Evidence and practical considerations
Side effects & toxicity
A conditional grapefruit precaution is supported for oral verapamil; measured juice exposure increases are not proof of toxicity from every fruit portion or botanical preparation.
- Exact scope
- Oral verapamil with grapefruit flesh. The clinical PK studies used juice, while NHS guidance explicitly includes fruit. with Current RxNorm confirms verapamil RxCUI 11170 IN. Oral racemic hydrochloride PM capsules 100, 200 or 300 mg; short-acting oral trial formulations distinguished and no IV transfer.
- Medication form and route
- Oral
What remains uncertain
- Juice PK studies are small and conflicting, without significant PD changes; fruit avoidance comes from exact-drug guidance. No quantified flesh toxicity or all-extract equivalence.
Factors that may matter: Exact preparation and dose; Oral formulation; Blood pressure and pulse; Other medicines.
Read the supporting source summaries
Source 1: Current prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed verapamil hydrochloride extended-release capsules (PM).
May raise exposure with grapefruit juice, but label expects no clinical consequences from the cited small study. Does not alter total serum calcium; above-normal calcium might alter effect. Bradycardia and hypotension warnings.
How this applies: Exact ingredient through the stated labeled salt and oral formulation. Current RxNorm confirms verapamil RxCUI 11170 IN. Oral racemic hydrochloride PM capsules 100, 200 or 300 mg; short-acting oral trial formulations distinguished and no IV transfer.
No universal calcium/multivitamin avoidance or timing rule; juice study does not quantify flesh toxicity.
Source 2: Original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Nine healthy men in a crossover.
S- and R-verapamil AUC increased 36% and 28%; no significant BP, heart-rate or PR-interval difference.
How this applies: Exact preparation and endpoint boundaries retained; this is not a measured verapamil combination unless explicitly stated.
Abstract-only; repeated juice exposure and small healthy sample, not toxicity incidence or every fruit/extract preparation.
Source 3: Original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Ten hypertensive patients on chronic short-acting verapamil.
No significant change in verapamil peak, time to peak or AUC.
How this applies: Exact preparation and endpoint boundaries retained; this is not a measured verapamil combination unless explicitly stated.
Abstract-only; short study and different juice regimen. Null result is not proof that repeated use is harmless.
Source 4: National health-service guidance
nhs.uk · Source check Sep 10, 2026
Population: People prescribed verapamil.
Advises avoiding grapefruit fruit and juice because levels and side effects may increase; keep prescribed treatment and avoid driving if dizzy.
How this applies: Explicit fruit/juice precaution for exact drug.
Guidance is broader than the small juice trials; no flesh-specific effect size or dose gap supplied.
Source 5: Medication terminology
rxnav.nlm.nih.gov · Source check Sep 10, 2026
Population: Terminology.
verapamil is IN.
How this applies: Exact ingredient.
Not clinical evidence.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Sources checked and article drafted. | |
| Research summary published |
Article revision: 3c07cec2930c9998
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.